Measures activity, not value. Not investment advice.
Shares rose 51% in six months as quarterly revenue grew 6.3% and yearly profit rose 12%.
WatchNews volume 13 times its usual week: 26 articles in seven days
Written by AI from the data on this page, 21 Nov 2026. Not investment advice.
Profile and fundamentals
From its SEC filings, 12 months to 30 Sep 2026
Mettler-Toledo supplies weighing and precision instruments to customers in the life sciences (around 55% of sales), industrial (around 40%), and food retail (around 5%) industries. Its products include laboratory and retail scales, pipettes, pH meters, thermal analysis equipment, titrators, metal detectors, and X-ray analyzers. Mettler leads the market for weighing instrumentation and controls more than 50% of the market for lab balances. The business is geographically diversified, with the Americas accounting for about 37% of sales, Europe about 27%, China about 16% and the rest of the world about 20%.
expected around 4 Feb 2027 (an estimate: a year ago it reported on 5 Feb 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $1.1B, net income $246.0M.
31 Dec 2021RevenueNet incometallest bar $1.1B30 Sep 2026
See the numbers
Quarter to
Revenue
Net income
30 Sep 2026
$1.1B
$246.0M
30 Jun 2026
$1.0B
$232.9M
31 Mar 2026
$947.1M
$169.5M
31 Dec 2025
$1.1B
$285.8M
30 Sep 2025
$1.0B
$217.5M
30 Jun 2025
$983.2M
$202.3M
31 Mar 2025
$883.7M
$163.6M
31 Dec 2024
$1.0B
$252.3M
30 Sep 2024
$954.5M
$211.5M
30 Jun 2024
$946.8M
$221.8M
31 Mar 2024
$925.9M
$177.5M
31 Dec 2023
$935.0M
$184.8M
30 Sep 2023
$942.5M
$201.6M
30 Jun 2023
$982.1M
$213.9M
31 Mar 2023
$928.7M
$188.4M
31 Dec 2022
$1.1B
$188.4M
30 Sep 2022
$985.8M
$220.6M
30 Jun 2022
$978.4M
$212.1M
31 Mar 2022
$897.8M
$174.0M
31 Dec 2021
$1.0B
$174.0M
Fundamentals, 12 months to 30 Sep 2026
Measure
Latest
Year before
Peer median
RevenueiSales over the last 12 months reported.
$4.2B
$3.9B
Revenue growthiRevenue of the last 12 months compared with the 12 months before.
+6.5%
+5.0%
Net incomeiProfit after all costs and taxes over the last 12 months reported. Negative is a loss.
$934.1M
$835.7M
EPS (diluted)iEarnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split).
$46.10
$40.07
Gross marginiWhat is left of each dollar of sales after the direct cost of making the product or service.
60.4%
59.7%
49.6%
Operating marginiOperating income as a share of sales: profit from the business before interest and taxes.
–
–
-7.0%
Net marginiNet income as a share of sales: what the owners keep of each dollar sold.
22.2%
21.2%
-10.8%
Return on equityiNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money.
–
-17.0%
Free cash flowiCash from operations minus capital spending over the last 12 months: cash the business produced.
$870.6M
$889.5M
CashiCash, cash equivalents and short-term investments on the latest balance sheet.
$52.2M
$69.1M
DebtiShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted.
$2.0B
$2.2B
Net debtiDebt minus cash. Negative means the company holds more cash than it owes (net cash).
$2.0B
$2.1B
Debt to equityiDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative.
26.1
0.45
Book value per shareiShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding.
$3.90
P/EiPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss.
35.5
33.4
P/SiPrice to sales: market cap divided by revenue of the last 12 months.
7.9
4.1
EV/SalesiEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months.
8.4
4.0
P/BiPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative.
427
2.4
Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.
Peers nearest by market cap, its own industry first
Insider Buy/Sell iShares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.
-$2.1M
bought $0, sold $2.1M
Institutional holders iThe number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.
+5.9%
832 13F filers vs 786
Institutional ownership iShares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.
over 100%
19.9M shares held by 13F filers (30 Sep 2026) of 19.9M outstanding (30 Sep 2026); above 100%: the share count is probably stale
Short interest iShares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.
3.1%
616K shares sold short (30 Oct 2026) of 19.9M outstanding (30 Sep 2026)
Days to cover iShort interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.
3.4
616K shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it
Short interest change iHow the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.
-6.3%
658K shares sold short in the report before, 616K on 30 Oct 2026
Short sale volume iShare of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.
35%
35% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 55%
Open jobs iJob postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.
–
We do not track this company's careers site yet.
Open jobs change iHow the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.
–
We do not track this company's careers site yet.
Employees iTotal staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.
–
No headcount in its annual reports in our data.
Visa hiring (foreign workers) iApplications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.
-25%
9 vs 12 applications
Revenue growth iSales in the latest reported quarter compared with the same quarter a year earlier.
+6.3%
$1.1B vs $1.0B (quarter ended 30 Sep 2026)
Capital spending iMoney spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.
+11%
$27.1M vs $24.5M (quarter ended 30 Sep 2026)
Federal contracts iMoney the US government committed to the company in contracts and grants over the last 12 months.
–
No data for this company
Lobbying iWhat the company reported spending on federal lobbying over the last four quarters.
–
No data for this company
Layoff notices iWorkers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).
–
No data for this company
News (7d) iArticles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.
29
29 articles in the last 7 days; its usual week has 2 (the median of the 26 weeks before).
News vs usual iArticles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.
14×
29 articles in the last 7 days; its usual week has 2.
Price $1,666.88 on 20 Nov 2026, +19% over 12 months (12-month range $1,025.53 to $1,762.28)
Sharp change
8-K and other filings
Insider net buying (open market). Insiders sold a net $8.0M in the last 12 months (the 12 months before: -$35.5M).H-1B/E-3 applications certified. H-1B/E-3 applications certified: 9 published in the last 12 months, -25% on the 12 months before.Revenue per quarter. Revenue $1.1B in the latest quarter, +6.3% on a year earlier.Capital spending per quarter. Capital spending $27.1M in the latest quarter, +11% on a year earlier.Institutional holders (13F filers). 832 13F filers reported holding it in the latest 13F quarter, +11% on a year earlier.
Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: federal obligations, lobbying spend, workers in warn layoff notices.
Quarter ended 31 Dec 2021: $1.0B, +11% on a year earlier; public on 12 Feb 2022
Quarter ended 31 Mar 2022: $897.8M, +12% on a year earlier; public on 7 May 2022
Quarter ended 30 Jun 2022: $978.4M, +5.8% on a year earlier; public on 30 Jul 2022
Quarter ended 30 Sep 2022: $985.8M, +3.6% on a year earlier; public on 5 Nov 2022
Quarter ended 31 Dec 2022: $1.1B, +2.0% on a year earlier; public on 11 Feb 2023
Quarter ended 31 Mar 2023: $928.7M, +3.4% on a year earlier; public on 6 May 2023
Quarter ended 30 Jun 2023: $982.1M, +0.4% on a year earlier; public on 29 Jul 2023
Quarter ended 30 Sep 2023: $942.5M, -4.4% on a year earlier; public on 10 Nov 2023
Quarter ended 31 Dec 2023: $935.0M, -12% on a year earlier; public on 10 Feb 2024
Quarter ended 31 Mar 2024: $925.9M, -0.3% on a year earlier; public on 11 May 2024
Quarter ended 30 Jun 2024: $946.8M, -3.6% on a year earlier; public on 3 Aug 2024
Quarter ended 30 Sep 2024: $954.5M, +1.3% on a year earlier; public on 9 Nov 2024
Quarter ended 31 Dec 2024: $1.0B, +12% on a year earlier; public on 8 Feb 2025
Quarter ended 31 Mar 2025: $883.7M, -4.6% on a year earlier; public on 3 May 2025
Quarter ended 30 Jun 2025: $983.2M, +3.9% on a year earlier; public on 2 Aug 2025
Quarter ended 30 Sep 2025: $1.0B, +7.9% on a year earlier; public on 8 Nov 2025
Quarter ended 31 Dec 2025: $1.1B, +8.1% on a year earlier; public on 7 Feb 2026
Quarter ended 31 Mar 2026: $947.1M, +7.2% on a year earlier; public on 9 May 2026
Quarter ended 30 Jun 2026: $1.0B, +4.5% on a year earlier; public on 1 Aug 2026
Quarter ended 30 Sep 2026: $1.1B, +6.3% on a year earlier; public on 7 Nov 2026
Capital spending per quarter
Quarter ended 31 Dec 2021: $37.8M, +7.8% on a year earlier; public on 12 Feb 2022
Quarter ended 31 Mar 2022: $19.2M, -22% on a year earlier; public on 7 May 2022
Quarter ended 30 Jun 2022: $43.2M, +90% on a year earlier; public on 30 Jul 2022
Quarter ended 30 Sep 2022: $26.8M, +20% on a year earlier; public on 5 Nov 2022
Quarter ended 31 Dec 2022: $32.0M, -15% on a year earlier; public on 11 Feb 2023
Quarter ended 31 Mar 2023: $23.2M, +21% on a year earlier; public on 6 May 2023
Quarter ended 30 Jun 2023: $28.8M, -34% on a year earlier; public on 29 Jul 2023
Quarter ended 30 Sep 2023: $21.0M, -22% on a year earlier; public on 10 Nov 2023
Quarter ended 31 Dec 2023: $32.4M, +1.2% on a year earlier; public on 10 Feb 2024
Quarter ended 31 Mar 2024: $17.4M, -25% on a year earlier; public on 11 May 2024
Quarter ended 30 Jun 2024: $23.8M, -17% on a year earlier; public on 3 Aug 2024
Quarter ended 30 Sep 2024: $21.4M, +2.2% on a year earlier; public on 9 Nov 2024
Quarter ended 31 Dec 2024: $41.3M, +27% on a year earlier; public on 8 Feb 2025
Quarter ended 31 Mar 2025: $17.3M, -0.8% on a year earlier; public on 3 May 2025
Quarter ended 30 Jun 2025: $23.9M, +0.3% on a year earlier; public on 2 Aug 2025
Quarter ended 30 Sep 2025: $24.5M, +14% on a year earlier; public on 8 Nov 2025
Quarter ended 31 Dec 2025: $41.5M, +0.6% on a year earlier; public on 7 Feb 2026
Quarter ended 31 Mar 2026: $17.4M, +0.9% on a year earlier; public on 9 May 2026
Quarter ended 30 Jun 2026: $27.8M, +16% on a year earlier; public on 1 Aug 2026
Quarter ended 30 Sep 2026: $27.1M, +11% on a year earlier; public on 7 Nov 2026
Institutional holders (13F filers)
31 Dec 2021 report: 691; public on 14 Feb 2022
31 Mar 2022 report: 686; public on 16 May 2022
30 Jun 2022 report: 684; public on 15 Aug 2022
30 Sep 2022 report: 635; public on 14 Nov 2022
31 Dec 2022 report: 671; public on 14 Feb 2023
31 Mar 2023 report: 712; public on 15 May 2023
30 Jun 2023 report: 694; public on 14 Aug 2023
30 Sep 2023 report: 674; public on 14 Nov 2023
31 Dec 2023 report: 711; public on 14 Feb 2024
31 Mar 2024 report: 737; public on 15 May 2024
30 Jun 2024 report: 747; public on 14 Aug 2024
30 Sep 2024 report: 738; public on 14 Nov 2024
31 Dec 2024 report: 780; public on 14 Feb 2025
31 Mar 2025 report: 773; public on 15 May 2025
30 Jun 2025 report: 747; public on 14 Aug 2025
30 Sep 2025 report: 750; public on 14 Nov 2025
31 Dec 2025 report: 809; public on 17 Feb 2026
31 Mar 2026 report: 799; public on 15 May 2026
30 Jun 2026 report: 786; public on 14 Aug 2026
30 Sep 2026 report: 832; public on 16 Nov 2026
What is unusual now
Nothing unusual in the last 90 days: no change appeared. Its most unusual measure now is research and development expense, quarter at $53.6M (30 Sep 2026), 1.1× its normal quarter; higher than 100% of its own history.
Reported lobbying spend: $13K in Q2 2018. Rows are lobbying firms hired or let go; amounts are reported per quarter, not per firm here.
Date
Change
Lobbying firm
Issue
Source
30 Jun 2018
Ended
Frost Brown Todd LLCfor Mettler-Toledo International Inc.
Lobbying related to letter dated May 8, 2018 addressed to U.S. Trade Representative Robert Lighthizer regarding Section 301 of the Trade Act of 1974.Trade
Frost Brown Todd LLCfor Mettler-Toledo International Inc.
Lobbying related to letter dated May 8, 2018 addressed to U.S. Trade Representative Robert Lighthizer regarding Section 301 of the Trade Act of 1974Trade
had 706K shares sold short in the 15 Aug 2025 report, 2.8× the same report last year.
Same report last year: 252K; its normal report is 348K.
See the evidence
This period
706K (the 15 Aug 2025 report)
Normal report (median of 24 earlier)
348K
Typical spread (median absolute deviation)
67K
How far from its usual level
+3.6
Same report last year
252K
History used
2,786 days
the 15 Aug 2025 report24 earlier reportsnormal: 348K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 684K shares sold short in the 31 Jul 2025 report, 2.3× the same report last year.
Same report last year: 296K; its normal report is 346K.
See the evidence
This period
684K (the 31 Jul 2025 report)
Normal report (median of 24 earlier)
346K
Typical spread (median absolute deviation)
63K
How far from its usual level
+3.6
Same report last year
296K
History used
2,771 days
the 31 Jul 2025 report24 earlier reportsnormal: 346K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 634K shares sold short in the 15 Jul 2025 report, 2.4× the same report last year.
Same report last year: 261K; its normal report is 336K.
See the evidence
This period
634K (the 15 Jul 2025 report)
Normal report (median of 24 earlier)
336K
Typical spread (median absolute deviation)
54K
How far from its usual level
+3.7
Same report last year
261K
History used
2,755 days
the 15 Jul 2025 report24 earlier reportsnormal: 336K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 624K shares sold short in the 13 Jun 2025 report, 1.8× the same report last year.
Same report last year: 349K; its normal report is 334K.
See the evidence
This period
624K (the 13 Jun 2025 report)
Normal report (median of 24 earlier)
334K
Typical spread (median absolute deviation)
44K
How far from its usual level
+4.5
Same report last year
349K
History used
2,723 days
the 13 Jun 2025 report24 earlier reportsnormal: 334K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 726K shares sold short in the 30 May 2025 report, 2.1× the same report last year.
Same report last year: 343K; its normal report is 334K.
See the evidence
This period
726K (the 30 May 2025 report)
Normal report (median of 24 earlier)
334K
Typical spread (median absolute deviation)
38K
How far from its usual level
+6.9
Same report last year
343K
History used
2,709 days
the 30 May 2025 report24 earlier reportsnormal: 334K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 611K shares sold short in the 15 May 2025 report, 1.7× the same report last year.
Same report last year: 362K; its normal report is 334K.
See the evidence
This period
611K (the 15 May 2025 report)
Normal report (median of 24 earlier)
334K
Typical spread (median absolute deviation)
33K
How far from its usual level
+5.5
Same report last year
362K
History used
2,694 days
the 15 May 2025 report24 earlier reportsnormal: 334K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 530K shares sold short in the 30 Apr 2025 report, 1.5× the same report last year.
Same report last year: 345K; its normal report is 334K.
See the evidence
This period
530K (the 30 Apr 2025 report)
Normal report (median of 24 earlier)
334K
Typical spread (median absolute deviation)
26K
How far from its usual level
+3.9
Same report last year
345K
History used
2,679 days
the 30 Apr 2025 report24 earlier reportsnormal: 334K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 546K shares sold short in the 15 Apr 2025 report, 1.6× the same report last year.
Same report last year: 347K; its normal report is 334K.
See the evidence
This period
546K (the 15 Apr 2025 report)
Normal report (median of 24 earlier)
334K
Typical spread (median absolute deviation)
22K
How far from its usual level
+4.2
Same report last year
347K
History used
2,664 days
the 15 Apr 2025 report24 earlier reportsnormal: 334K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
spent $43.2M on capital projects in the quarter ended 30 Jun 2022, 1.9× the same quarter last year.
Same quarter last year: $22.8M; its normal quarter is $22.6M.
See the evidence
This period
$43.2M (the quarter ended 30 Jun 2022)
Normal quarter (median of 8 earlier)
$22.6M
Typical spread (median absolute deviation)
$2.9M
How far from its usual level
+4.9
Same quarter last year
$22.8M
History used
4,656 days
the quarter ended 30 Jun 20228 earlier quartersnormal: $22.6M
Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $5.0M.
Fires on an 8-K with item 5.02 after 90 days without one.
Showing the newest 40 of 51 entries; narrow the window or the kind of data to see older ones.
Not listed: 454 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.
Identifiers and sources
How records are matched to this company, and what each source holds for it
Cik
0001037646
Ticker
MTD
Domain
mt.com
Employer name
Mettler-Toledo, LLC (1 unverified)
Hq location
OH|COLUMBUS|43240 (1 unverified)
Lobbying client
mettler toledo international
Name
Austria, Barbados, Croatia, Czech Republic and 16 more
Wikidata
Q680186
Wikipedia
Mettler Toledo
DOL H-1B labor condition applications and PERM certifications329 data points21 Oct 2019 to 17 Aug 2026
Federal lobbying disclosures (LDA)2 records, 3 data points27 Apr 2018 to 30 Jun 2018
SEC Form 13F institutional holdings3 records, 481 data points30 Jun 2013 to 30 Sep 2026
SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)120 records4 Feb 2016 to 6 Nov 2026
SEC XBRL company facts (revenue, capex, R&D, backlog...)1111 data points31 Dec 2007 to 30 Sep 2026
SEC Form 4 insider transactions359 records, 936 data points10 Feb 2016 to 10 Nov 2026
FINRA short interest (twice monthly)624 data points29 Dec 2017 to 30 Oct 2026
FINRA daily short sale volume (off-exchange)4178 data points1 Aug 2018 to 20 Nov 2026
Wikipedia pageviews2881 data points1 Jan 2019 to 20 Nov 2026